Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer
Year: 2017
Type: article
Source: Current Pharmaceutical Design
Institutions: Steno Diabetes Center Copenhagen, Zealand University Hospital
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: trimethylamine N-oxide, insulin resistance, gastrointestinal cancer, gut microbiota, trimethylamine, choline, L-carnitine, animal products, dietary intervention, N-nitroso compounds, DNA damage, epigenetic modifications, meldonium, 3,3-dimethyl-1-butanol, therapeutic target, atherosclerotic cardiovascular disease
Open Access status: closed
Funder: Steno Diabetes Center Copenhagen
Award: G6433152044
OpenAlex ID: W2648593275
